GSA CAPITAL PARTNERS LLP

Position in A — Agilent Technologies, Inc.

CIK 1362033 LONDON, X0

Position in A

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$994,019

+$274,753 QoQ

Shares Held

8,721

+65.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $12,036,211 across 17 Diagnostics & Research names. A ranks #4 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DHR	Danaher Corp /De/	13,542	$2,567,563
2	IDXX	Idexx Laboratories Inc /De	2,801	$1,573,853
3	MYGN	Myriad Genetics Inc	339,902	$1,529,559
4	A	Agilent Technologies, Inc. This page	8,721	$994,019
5	XGN	Exagen Inc.	253,005	$759,015
6	OPK	Opko Health, Inc.	663,704	$756,622
7	BDSX	Biodesix Inc	39,406	$571,387
8	PSNL	Personalis, Inc.	82,175	$523,454

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$994,019	8,721	+65.0%	Shares	Sole	2026-05-08
2025-12-31	$719,266	5,286	-43.5%	Shares	Sole	2026-02-06
2025-06-30	$1,103,865	9,354	+210.7%	Shares	Sole	2025-07-22
2025-03-31	$352,226	3,011	+26.7%	Shares	Sole	2025-05-08
2024-12-31	$319,326	2,377	-29.3%	Shares	Sole	2025-02-07
2024-09-30	$499,338	3,363	+31.1%	Shares	Sole	2024-11-05
2023-06-30	$308,561	2,566	-69.0%	Shares	Sole	2023-08-14
2021-09-30	$1,303,560	8,275	+308.8%	Shares	Sole	2021-11-12
2021-06-30	$299,167	2,024	-30.4%	Shares	Sole	2021-08-05
2021-03-31	$369,595	2,907	+30.7%	Shares	Sole	2021-05-10
2020-12-31	$263,521	2,224	—	Shares	Sole	2021-02-03
No filing history on record for this holder in this stock.